Amorphous is not always better—A dissolution study on solid state forms of carbamazepine
- 1 April 2017
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 522 (1-2) , 74-79
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
- Københavns Universitet
This publication has 20 references indexed in Scilit:
- Inhibition of Crystal Nucleation and Growth by Water-Soluble Polymers and its Impact on the Supersaturation Profiles of Amorphous DrugsJournal of Pharmaceutical Sciences, 2013
- Hot melt extrusion (HME) for amorphous solid dispersions: Predictive tools for processing and impact of drug–polymer interactions on supersaturationEuropean Journal of Pharmaceutical Sciences, 2013
- Dissolution Rate and Apparent Solubility of Poorly Soluble Drugs in Biorelevant Dissolution MediaMolecular Pharmaceutics, 2010
- Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Influence of polymeric excipients on crystal hydrate formation kinetics in aqueous slurriesJournal of Pharmaceutical Sciences, 2008
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- Influence of Polymorphic Form, Morphology, and Excipient Interactions on the Dissolution of Carbamazepine CompactsJournal of Pharmaceutical Sciences, 2007
- Visualizing the conversion of carbamazepine in aqueous suspension with and without the presence of excipients: A single crystal study using SEM and Raman microscopyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compoundsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorderInternational Journal of Pharmaceutics, 2002